Acid, protons and Helicobacter pylori

Yale Journal of Biology and Medicine

Volumn 69, Issue 3, 1996, Pages 301-316

  Sachs, George ^a   Meyer Rosberg, Karin ^b   Scott, David R ^b   Melchers, Klaus ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; STOMACH SECRETION INHIBITOR; UREASE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DRUG POTENTIATION; ENZYME ACTIVITY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MEMBRANE POTENTIAL; NONHUMAN; PEPTIC ULCER; PH; PROTON MOTIVE FORCE; PROTON TRANSPORT; REVIEW;

GASTRIC ACID; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; PROTON PUMPS; PROTONS;

EID: 0030441270     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Schwartz, K. Ueber penetrierende Magen-und Jejunal Geschuere. Beitr. Klin. Chirugie 5:98-109, 1910.
2. 2 -receptors. Nature 236:385-390, 1972.
3. Sachs, G., Carlsson, E., Lindberg, P,. and Wallmark, B. Gastric H,K-ATPase as therapeutic target. Ann. Rev. Pharmacol. Toxicol. 28:269-284, 1988.
4. Warren, J.R. and Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275, 1983.
5. Walsh, J.H. and Peterson, W.L. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333:984-991, 1995.
6. Hopkins, R.J., Girardi, L.S., and Turney, E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110:1244-1252, 1996.
7. Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., Havu, N., Festen, H.P., Liedman, B., Lamers, C.B., Jansen, J.B., Dalenback, J., Snel, P., Nelis, G.F., and Meuwissen, S.G. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med. 334:1018-1022, 1996.
8. Sipponen, P., Riihela, M., Hyvarinen, H., and Seppala, K. Chronic nonatrophic gastritis increases the risk of gastric carcinoma. Scand. J. Gastroenterol. 29:336-340, 1994.
9. Parsonnet, J., Friedman, G.D., Vandersteed, D.P., et al. H. pylori infection and the risk of gastric cancer. N. Engl. J. Med. 325:1131-1133, 1991.
10. Logan, R.P.H., Walker, M.M., Misiewicz, J.J., Kirk, G.E., Hawkey, C.J., and Spiller R.C. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole Gut 36, 12-16, 1995.
11. Bell, N.J., Burget, D., Howden, C.W., Wilkinson, J., and Hunt, R.H. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 51(suppl 1):59-67, 1992.
12. Burget, D.W., Chiverton, S.G., and Hunt, R.H. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 99:345-351, 1990.
13. Wilkes, J.M., Kajimura, M., Scott, D.R., Hersey, H.J., and Sachs, G. Muscarinic responses of gastric parietal cells. J. Memb. Biol. 122:97-110, 1991.
14. Nwokolo, C.U., Smith, J.T. Gavey, C., Sawyer, A. and Pounder, R.E. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment. Pharmacol. Ther. 4(suppl 1):29-45, 1990.
15. Helander, H.F., Ramsay, C.H., and Regardh, C.G. Localization of omeprazole and metabolites in the mouse. Scan. J. Gastroentorol. 108(suppl):95-104, 1985.
16. Scott, D.R., Helander, H.F., Hersey, S.J., and Sachs, G. The site of acid secretion in the mammalian parietal cell. Biochim. Biophys. Acta. 1146:73-80, 1993.
17. + ATPase. Am. J. Physiol. 245:G589-G596.
18. +-adenosinetriphosphatase. Biochemistry 32:2345-2355, 1993.
19. Sachs, G.J., Shin, M., Besancon, M., and Prinz, C. The continuing development of gastric acid pump inhibitors. Aliment. Pharmacol. Ther. 7(suppl 1):4-12, 1993.
20. +-ATPase. Biochim. Biophys. Acta, 1148:223-233, 1993.
21. +-ATPase. Biochim. Biophys. Acta. 1149:151-165, 1993.
22. Bamberg, K. and Sachs, G. Topological analysis of the H,K-ATPase by in vitro translation. J. Biol. Chem. 269:16909-16919, 1994.
23. Andersen, J.P. and Vilsen, B. Structure function relationships of cation translocation by Ca and Na,K ATPases studied by site directed mutagenesis FEBS Lett. 359:101-106, 1995.
24. Lingrel, J.B. and Kuntzweiler, T. Na,K ATPase. J. Biol. Chem. 269:19659-19662, 1994.
25. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 265:6262-6267, 1990.
26. Van Huysse, J.W., Jewell, E.W., and Lingrel, J.B. Site-directed mutagenesis of a predicted cation binding site of Na, K-ATPase. Biochemistry 32:819-826, 1993.
27. +-ATPase sites that react selectively with the benzimidazole class of antiulcer drugs. Gastroenterology 104:A192, 1993.
28. Walan, A., Bader, J.P., Classen, M., Lamers, B.H.W., Piper, D W., Rutgersson, K., and Eriksson, S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N. Engl. J. Med. 32:69-75, 1989.
29. Hawkey, C.J., Long, R.G., Bardhan, K.D., et al Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine Gut 34:1458-1462, 1993.
30. Koop, H., Schepp, W., Damman, H.G., et al Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: results of a German multicenter study. J. Clin. Gastroenterol. 20:192-195, 1995.
31. Bell, G.D., Bate, C.M., Axon, A.T., Tildesley, G., Kerr, G.D., Green, J.R., Emmas, C.E., and Taylor, M.D. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment. Pharmacol. Ther. 9:513-20, 1995
32. Bertoni, G., Sassatelli, R., Nigrisoli, E., Tansini, P., Bianchi, G., Della Casa, G., Bagni, A., and Bedogni, G. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am. J. Gastroenterol. 91:258-63, 1996.
33. Mitchell, P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol. Rev. 41:445-502, 1996.
34. Paradiso, A.M., Tsien R.Y., and Machen T.E. Digital image processing of intracellular pH in gastric oxyntic and chief cells. Nature 325:447-50, 1987.
35. Meyer-Rosberg, K., Scott, D.R., Rex, D., Melchers, K., and Sachs, G. The effect of environmental pH on the Proton Motive force of Helicobacter pylori. Gastroenterology. In press.
36. Kashket, E.R. The proton motive force in bacteria: a critical assessment of methods Ann. Rev. Microbiol. 39:219-242, 1985.
37. Waggoner, A.S. Optical probes of membrane potential. J. Membr. Biol. 27:317-34, 1976.
38. Matin, A., Zychlinsky, E., Keyahn, M., and Sachs, G. The capacity of Helicobacter pylori to generate ionic gradients at low pH is similar to that of bacteria that grow under strongly acidic conditions. Infect. Immun. 64:1434-1436, 1996.
39. Morgan, D.R., Freedman, F., Depew, C.E., and Kraft, W.G. Growth of Campylobacter in liquid media. J. Clin. Microbiol. 25:2123-2125, 1987.
40. Clyne, M., Labigne, A., and Drumm, B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect. Immun. 63:1669-1673, 1995.
41. Eaton, K.A., Morgan. D.R., Brooks, C.L., and Krakowka, S. Essential role of urease in the pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59:2470-2475, 1991.
42. Tsuda, M., Karita, M., Morshed, M.G., Okita, K., and Nakazawa, T. A urease negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect. Immun. 62:3586-3589, 1994.
43. Lee, A., Dixon, M.F., Danon, S.J., Kuipers, E., Megraud, F., Larsson, H. and Mellgard, B. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease Europ. J. Gastroenterol. Hepatol. 7:461-465, 1995.
44. Schade, C., Flemstrom, G., and Holm, L. Hydrogen ion concentration in the mucus layer on top of acid-stimulated and -inhibited rat gastric mucosa. Gastroenterology 107:180-188, 1994.
45. Bardhan, K.D., Dekkers, C.P., Lam S.K., Nowak, A., Schaffalitzky de Muckadell, O.B., Schutze, K., Tildesley, G., Kler, L., Forster, J.K., Lacey, L.F., et al. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment. Pharmacol. Ther. 9:497-506, 1995.
46. Lind, T., Veldhuyzen van Zanten, S.J.O., Unge, P., et al. The MACH 1 study: optimal 1 week treatment for H. pylori defined? Gut(suppl 1):A4, 1995.
47. Logan, R.P.H., Walker, M.M., Misiewicz, J.J., Kirk, G.E., Hawkey, C.J. and Spiller R.C. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole Gut 36:12-16, 1995.